CASI Price Targets and Analyst Ratings NASDAQ:CASI
CASI Forecast. What You Should Know.
CASI Historical Ratings and Targets
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.